Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Sep 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 83032101000001110 | Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 83032201000001115 | Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutioninjection.intramuscular ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Intramuscular route | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Is a | Lidocaine + Adrenaline | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Is a | Product containing epinephrine and lidocaine | false | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has active ingredient | Epinephrine | false | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has active ingredient | Lidocaine | false | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has specific active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has specific active ingredient | Epinephrine | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (Special Order) | Is a | True | Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Inferred relationship | Existential restriction modifier | |
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 10 ampoule | Has VMP | True | Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Inferred relationship | Existential restriction modifier | |
| Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has VMP | True | Lidocaine 200mg/10ml (2%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR